Next Century Growth Investors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
VCM
VPM
Next Century Growth Investors's ADPT Position: Q1 2026 in Review
Next Century Growth Investors reduced its Adaptive Biotechnologies (ADPT) stake by 47% in Q1 2026, selling an estimated $7M and leaving 504,346 shares worth $7M. The position accounts for 0.51% of the portfolio, ranked #65.
Next Century Growth Investors first reported a position in ADPT in Q3 2025 and has held it in 3 quarters since. The position peaked at $15.3M in Q4 2025. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.
- Next Century Growth Investors held 504,346 shares of Adaptive Biotechnologies worth $7M as of Q1 2026.
- Next Century Growth Investors sold 439,251 Adaptive Biotechnologies shares in Q1 2026, an estimated $7M.
- Adaptive Biotechnologies made up 0.51% of Next Century Growth Investors's portfolio in Q1 2026, its #65 holding.
- Next Century Growth Investors first reported a position in Adaptive Biotechnologies in Q3 2025 and has held it in 3 quarters since.
- Next Century Growth Investors's Adaptive Biotechnologies position peaked at $15.3M in Q4 2025.
- 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.
Based on Next Century Growth Investors's 13F filing for Q1 2026, filed 14 May 2026.